Kidney cancer

The Teknon Oncology Institute is a pioneer in antiangiogenic therapies and immunotherapy for metastatic kidney cancer. As in the case of prostate cancer, a multidisciplinary approach involving urologists, radiation oncologists, radiologists and pathologists is standard practice at our centre.

In the last two years, immunotherapy has been incorporated as an effective treatment for renal carcinoma, replacing antiangiogenic drugs in some situations.